Medical Xpress news tagged with:respiratory syncytial virushttp://medicalxpress.com/
en-usMedical Xpress internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.Almost half of daycare children found to have respiratory virusForty-three per cent of children at two daycare centres researchers studied had at least one virus in their respiratory tract.http://medicalxpress.com/news/2016-11-daycare-children-respiratory-virus.html
Diseases, Conditions, SyndromesMon, 28 Nov 2016 09:20:02 ESTnews399546111Infants in Northern Canada face the highest rates of respiratory infection in the worldInfants in Canada's north are facing alarming rates of respiratory infection, but providing an antibody to all infants will prevent hundreds of hospitalizations of babies in the Arctic and save hundreds of thousands of dollars a year.http://medicalxpress.com/news/2016-10-infants-northern-canada-highest-respiratory.html
PediatricsTue, 18 Oct 2016 11:23:46 ESTnews396008620Infant nose, lung cells possess remarkably similar RNA patternsCells from an infant's nose are remarkably similar to those found in the lungs, a discovery that could lead to much more precise diagnosis of respiratory syncytial virus (RSV) and other infant lung diseases, according to new research from the University of Rochester Medical Center (URMC).http://medicalxpress.com/news/2016-10-infant-nose-lung-cells-remarkably.html
PediatricsFri, 14 Oct 2016 10:38:23 ESTnews395660290Vaccine for many common cold viruses achievableScientists are making the case that a vaccine against rhinoviruses, the predominant cause of the common cold, is achievable.http://medicalxpress.com/news/2016-09-vaccine-common-cold-viruses.html
Diseases, Conditions, SyndromesWed, 28 Sep 2016 07:45:13 ESTnews394267504RSV found in aerosol particles surrounding infants with RSV(HealthDay)—Infants with respiratory syncytial virus (RSV)-positive bronchiolitis produce large numbers of aerosol particles containing RSV that remain infectious for a significant length of time, according to a study published in the Aug. 1 issue of the American Journal of Respiratory and Critical Care Medicine.http://medicalxpress.com/news/2016-08-rsv-aerosol-particles-infants.html
Diseases, Conditions, SyndromesMon, 15 Aug 2016 12:30:03 ESTnews390477259Aviragen Therapeutics licenses Georgia State Technology to develop antiviral therapiesThe Georgia State University Research Foundation (GSURF) has entered into a licensing and sponsored research agreement with Aviragen Therapeutics, Inc., a Georgia-based pharmaceutical company developing the next generation of antivirals, to develop and commercialize respiratory syncytial virus (RSV) replication inhibitors.http://medicalxpress.com/news/2016-07-aviragen-therapeutics-georgia-state-technology.html
Diseases, Conditions, SyndromesTue, 05 Jul 2016 15:03:42 ESTnews386949814Drug that targets multiple drug-resistant strains of HIV and other viruses is ready for clinical trialsA research team spanning four continents has detailed the anti-viral capabilities of OSU-03012, also known as AR-12, a drug currently used in clinical trials to treat certain cancer tumors. The present study confirms that AR-12 is effective in treating a host of viral infections in the laboratory and in animal models, including multiple strains of drug-resistant HIV, Ebola, influenza, mumps and measles.http://medicalxpress.com/news/2016-07-drug-multiple-drug-resistant-strains-hiv.html
Medical researchTue, 05 Jul 2016 08:11:33 ESTnews386925036How immunity to RSV develops in childhood but deteriorates in adultsThe leading infectious cause of severe respiratory disease in infants, respiratory syncytial virus (RSV), is also a major cause of respiratory illness in the elderly. Approved vaccines do not yet exist, and despite the development of partial immunity following infection during childhood, individuals remain susceptible to RSV reinfection life-long. A comprehensive characterization of the antibody-response to RSV published on April 21st in PLOS Pathogens advances our understanding of the human immune response against RSV and has implications for vaccine design.http://medicalxpress.com/news/2016-04-immunity-rsv-childhood-deteriorates-adults.html
Diseases, Conditions, SyndromesThu, 21 Apr 2016 14:00:06 ESTnews380460216Bid to beat baby chest infection boosted by immune studyBabies at risk of a serious lung infection could be helped by a therapy based on the body's natural immune defences.http://medicalxpress.com/news/2016-03-baby-chest-infection-boosted-immune.html
ImmunologyMon, 07 Mar 2016 09:41:03 ESTnews376566055Chile researchers develop vaccine for virus common in childrenResearchers in Chile said Friday they have developed the first vaccine against a virus that commonly causes lung and respiratory tract infections in children.http://medicalxpress.com/news/2016-01-chile-vaccine-virus-common-children.html
Diseases, Conditions, SyndromesFri, 08 Jan 2016 14:34:40 ESTnews371486072Early childhood bronchiolitis increases asthma risk in adulthoodPersons who have had bronchiolitis in early childhood have an increased risk of asthma at the age of 28-31 and a weaker health-related quality of life than their peers. In lung function tests, they also demonstrate changes indicative of irreversible airway obstruction, according to a new study from the University of Eastern Finland.http://medicalxpress.com/news/2015-11-early-childhood-bronchiolitis-asthma-adulthood.html
Inflammatory disordersMon, 23 Nov 2015 11:11:38 ESTnews367499491Potential treatment for a serious respiratory infection in kids(HealthDay)—An experimental drug shows promise as a treatment for a common and potentially serious illness known as respiratory syncytial virus (RSV).http://medicalxpress.com/news/2015-11-potential-treatment-respiratory-infection-kids.html
Diseases, Conditions, SyndromesThu, 19 Nov 2015 15:27:04 ESTnews367169216Vaccine against respiratory syncytial virus shows promise in early trialJohns Hopkins Bloomberg School of Public Health researchers say a new candidate vaccine against respiratory syncytial virus (RSV) made with a weakened version of the virus shows great promise at fighting the disease, the leading cause of hospitalization for children under the age of one in the U.S.http://medicalxpress.com/news/2015-11-vaccine-respiratory-syncytial-virus-early.html
Diseases, Conditions, SyndromesWed, 04 Nov 2015 14:00:07 ESTnews365850883Sendai virus defends against a threatA research group at Hiroshima University demonstrated the mechanism by which the Sendai virus (SeV) escapes the host immune system. The researchers examined the crystal structure of the complex of SeV C protein and transcription factor STAT1, and found that SeV C protein inhibits the signal transduction pathway of interferon gamma. This discovery will allow the design of drugs that can be used to overcome recover from damage caused by interferon, wherein the drug acts by inhibiting the binding between C protein and STAT1. Researchers are now trying to screen low molecular weight compounds for developing new anti-viral drugs.http://medicalxpress.com/news/2015-10-sendai-virus-defends-threat.html
Medical researchThu, 15 Oct 2015 12:15:24 ESTnews364130106Team identifies viral product that promotes immune defense against RSVAlmost all human beings are exposed to the respiratory syncytial virus, or RSV, before their second birthdays. For most, the symptoms mimic those of the common cold: runny nose, coughing, sneezing, fever. But in some very young infants—and some older adults—the disease can be serious, causing respiratory problems that require hospitalization and increase the risk of developing asthma later in life.http://medicalxpress.com/news/2015-09-team-viral-product-immune-defense.html
Medical researchThu, 03 Sep 2015 18:32:33 ESTnews360523942Personal clothing may spread respiratory infections within the NICURespiratory syncytial virus (RSV), which is the leading cause of childhood respiratory hospitalizations among premature babies, can be detected from the clothes worn by caregivers/visitors who are visiting infants in the neonatal intensive care unit (NICU), according to research being presented at the International Conference on Emerging and Infectious Diseases in Atlanta, Georgia.http://medicalxpress.com/news/2015-08-personal-respiratory-infections-nicu.html
Diseases, Conditions, SyndromesMon, 24 Aug 2015 15:30:01 ESTnews359642139Vaccine combo shows promise against common, dangerous infectionResearchers report they are closer to finding a vaccine for respiratory syncytial virus (RSV), a common illness that few recognize by name but one that's a major cause of lower respiratory infection in babies and the elderly.http://medicalxpress.com/news/2015-08-vaccine-combo-common-dangerous-infection.html
Diseases, Conditions, SyndromesWed, 12 Aug 2015 16:22:28 ESTnews358615337Novavax: Early study indicates its vaccine effective vs. RSVEarly research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable Americans—babies and senior citizens.http://medicalxpress.com/news/2015-08-novavax-early-vaccine-effective-rsv.html
MedicationsMon, 10 Aug 2015 16:24:40 ESTnews358442672Viruses thrive in big families, in sickness and in healthThe BIG LoVE (Utah Better Identification of Germs-Longitudinal Viral Epidemiology) study, led by scientists at the University of Utah School of Medicine, finds that each bundle of joy puts the entire household at increased risk for infection with viruses that cause colds, flu, and other respiratory illnesses.http://medicalxpress.com/news/2015-08-viruses-big-families-sickness-health.html
Diseases, Conditions, SyndromesWed, 05 Aug 2015 02:16:41 ESTnews357959788Vaccine with virus-like nanoparticles effective treatment for RSV, study findsA vaccine containing virus-like nanoparticles, or microscopic, genetically engineered particles, is an effective treatment for respiratory syncytial virus (RSV), according to researchers at Georgia State University.http://medicalxpress.com/news/2015-08-vaccine-virus-like-nanoparticles-effective-treatment.html
Diseases, Conditions, SyndromesMon, 03 Aug 2015 11:30:01 ESTnews357818323Study in calves offers hope for respiratory-disease treatmentAs every parent knows, respiratory illnesses—complete with runny nose, sore throat and cough—are quite routine for young children and usually pass as quickly as they appear.http://medicalxpress.com/news/2015-07-calves-respiratory-disease-treatment.html
Diseases, Conditions, SyndromesFri, 24 Jul 2015 07:50:03 ESTnews356940002Study shows that augmenting a gas naturally in our bodies fights RSV infectionA new study from the University of Texas Medical Branch at Galveston is the first to show that hydrogen sulfide, a gas produced naturally within our bodies, reduces the severity of respiratory syncytial virus, or RSV. When someone has a RSV infection, his or her body is less able to produce the protective hydrogen sulfide. The UTMB study found that a drug that triggers a steady release of this gas decreases the virus's ability to multiply and reduces inflammation of the airways.http://medicalxpress.com/news/2015-04-augmenting-gas-naturally-bodies-rsv.html
Diseases, Conditions, SyndromesMon, 27 Apr 2015 12:51:29 ESTnews349357878Gene variant and environment can boost severity of respiratory syncytial virusA particular genetic mutation combined with an urban environment increases the risk of severe disease in children infected with respiratory syncytial virus (RSV), an international team of investigators has found.http://medicalxpress.com/news/2015-04-gene-variant-environment-boost-severity.html
Diseases, Conditions, SyndromesTue, 07 Apr 2015 12:16:21 ESTnews347627774Respiratory viruses most common cause of pneumonia in children, study findsRespiratory viruses, not bacterial infections, are the most commonly detected causes of community-acquired pneumonia in children, according to new research released Feb. 26 in the New England Journal of Medicine.http://medicalxpress.com/news/2015-02-respiratory-viruses-common-pneumonia-children.html
Diseases, Conditions, SyndromesWed, 25 Feb 2015 17:10:02 ESTnews344103409RSV infection may be associated with higher risk for bacterial pneumoniaTwo common and sometimes dangerous respiratory diseases, a viral one caused by respiratory syncytial virus (RSV), and a bacterial one caused by Streptococcus pneumoniae may be linked, suggests a study published in this week's PLOS Medicine.http://medicalxpress.com/news/2015-01-rsv-infection-higher-bacterial-pneumonia.html
Diseases, Conditions, SyndromesTue, 06 Jan 2015 14:00:04 ESTnews339773916New research shows fewer deaths related to RSV than previously thoughtIt's a virus that has long been characterized as dangerous and even deadly, but new research shows infant deaths from respiratory syncytial virus (RSV) are actually quite uncommon in the 21st century.http://medicalxpress.com/news/2014-12-deaths-rsv-previously-thought.html
PediatricsMon, 08 Dec 2014 10:21:52 ESTnews337256504Treatment strategy may reduce infants' wheezing caused by virus(Medical Xpress)—The antibiotic azithromycin may reduce the risk of recurrent wheezing in infants hospitalized with a common respiratory infection, according to a small pilot study at Washington University School of Medicine in St. Louis. Evidence suggests that reduced wheezing may lower an infant's risk of developing asthma over the next several years.http://medicalxpress.com/news/2014-11-treatment-strategy-infants-wheezing-virus.html
ImmunologyWed, 19 Nov 2014 07:00:02 ESTnews335601541Veterinary research on lambs leads to advances in treatments for respiratory disease in human infantsVeterinary research involving lambs at Iowa State University is helping to advance new treatments to a common virus in humans that sometimes poses a serious threat to newborns.http://medicalxpress.com/news/2014-10-veterinary-lambs-advances-treatments-respiratory.html
Medical researchThu, 23 Oct 2014 07:30:02 ESTnews333267138High hopes rest on 800 vials of experimental Ebola vaccine shipped from CanadaThe world has been warned that the current Ebola epidemic may not end without the use of a vaccine – and no licensed vaccines exist yet. That may soon change, because scientists are making swift progress.http://medicalxpress.com/news/2014-10-high-rest-vials-experimental-ebola.html
Diseases, Conditions, SyndromesWed, 22 Oct 2014 08:00:02 ESTnews333182067New perspectives for development of an RSV vaccineRespiratory Syncytial Virus causes severe respiratory tract infections and worldwide claims the lives of 160,000 children each year. Scientists at VIB and Ghent University have succeeded in developing a promising vaccination strategy to counteract this common virus infection.http://medicalxpress.com/news/2014-10-perspectives-rsv-vaccine.html
Diseases, Conditions, SyndromesThu, 16 Oct 2014 09:30:03 ESTnews332668399